Skip to main content

elbasvir/grazoprevir (Zepatier®)

 

Status: In progress

Treatment of chronic hepatitis C (CHC) in  paediatric patients 12 years of age and older who weigh at least 30 kg.

Medicine details

Medicine name elbasvir/grazoprevir (Zepatier®)
Formulation 50 mg/ 100 mg film-coated tablet
Reference number 4980
Indication

As above

Company Merck Sharp & Dohme Ltd
BNF chapter Infections
Submission type Licence extension for paediatric use
Status In progress
AWMSG meeting date 12/07/2022
Date of issue TBC
Follow AWTTC: